Wilkes-Barre General nurses anesthetists win union recognition citizensvoice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from citizensvoice.com Daily Mail and Mail on Sunday newspapers.
Kelly Conway, left, and her mother, Maureen Conway, pose for a photo at a COVID-19 vaccination site in January. Kelly made a 350-mile round trip from Montgomery County to get Maureen from her home in Plains Twp. to a vaccination provider in Montrose about two weeks ago. After seeing her father, Jim, suffer for two weeks before losing his life to COVID-19 on Nov. 10, Kelly wants to make sure her mother is vaccinated as soon as possible.
City police identified the victim as Angela Velazquez, 38, and confirmed the extent of her injuries.
âWe are worried about her future and her recovery,â said Velazquezâs sister Barbara McLean, 31, a Wilkes-Barre native now living in Hinesville, Georgia.
McClean said Velazquez, of Kingston, was on her way to get a money order to pay her rent when police say she was struck by a driver who traveled through a red traffic light at South Main and Northampton Streets.
She said Velazquez had walked from her home in Kingston to visit their mother in the Heights section of Wilkes-Barre, like she always does.
Another local medical provider is offering an intravenous antibody therapy that may help COVID-19 patients avoid hospital stays and recover more quickly with fewer complications.
The Wright Center for Community Health is now operating a Scranton outpatient infusion clinic administering the monoclonal antibody bamlanivimab, which received emergency use authorization as a COVID-19 treatment in November.
âMonoclonal antibodies are laboratory-made proteins that mimic the immune systemâs ability to fight off harmful pathogens like viruses,â according to the U.S. Food and Drug Administration. Developed by the pharmaceutical firm Eli Lilly and Co., bamlanivimab is a monoclonal antibody specifically directed against the spike protein of SARS-CoV-2, the virus that causes COVID-19. Itâs âdesigned to block the virusâ attachment and entry into human cells,â according to the FDA.